MakCHS Publications

Found 14 results
[ Author(Asc)] Keyword Title Type Year
Filters: First Letter Of Last Name is C  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
J. A. Cox, Lukande, R. L., Kalungi, S., Van Marck, E., Van de Vijver, K., Kambugu, A., Nelson, A. M., Colebunders, R., and Manabe, Y. C., Is Urinary Lipoarabinomannan the Result of Renal Tuberculosis? Assessment of the Renal Histology in an Autopsy Cohort of Ugandan HIV-Infected Adults., PLoS One, vol. 10, no. 4, p. e0123323, 2015.
J. A. Cox, Lukande, R. L., Kalungi, S., Van Marck, E., Lammens, M., Van de Vijver, K., Kambugu, A., Nelson, A. M., Colebunders, R., and Manabe, Y. C., Accuracy of Lipoarabinomannan and Xpert MTB/RIF Testing in Cerebrospinal Fluid To Diagnose Tuberculous Meningitis in an Autopsy Cohort of HIV-Infected Adults., J Clin Microbiol, vol. 53, no. 8, pp. 2667-73, 2015.
S. Cose, Bagaya, B., Nerima, B., Joloba, M., Kambugu, A., Tweyongyere, R., Dunne, D. W., Mbidde, E., Kaleebu, P., and Elliott, A. M., Immunology in Africa., Trop Med Int Health, vol. 20, no. 12, pp. 1771-7, 2015.
C. L. Cooper and Cameron, W. D., Interpretation of undetectable hepatitis C virus RNA levels in HIV-hepatitis C virus co-infection., AIDS (London, England), vol. 18, no. 2, pp. 337-8, 2004.
R. Colebunders, Moses, K. R., Laurence, J., Shihab, H. M., Semitala, F., Lutwama, F., Bakeera-Kitaka, S., Lynen, L., Spacek, L., Reynolds, S. J., Quinn, T. C., Viner, B., and Mayanja-Kizza, H., A new model to monitor the virological efficacy of antiretroviral treatment in resource-poor countries., The Lancet infectious diseases, vol. 6, no. 1, pp. 53-9, 2006.
D. Cohan, Natureeba, P., Koss, C. A., Plenty, A., Luwedde, F., Mwesigwa, J., Ades, V., Charlebois, E. D., Gandhi, M., Clark, T. D., Nzarubara, B., Achan, J., Ruel, T., Kamya, M. R., and Havlir, D. V., Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women., AIDS, vol. 29, no. 2, pp. 183-91, 2015.
L. Chola, Nkonki, L., Kankasa, C., Nankunda, J., Tumwine, J., Tylleskar, T., and Robberstad, B., Cost of individual peer counselling for the promotion of exclusive breastfeeding in Uganda, Cost Effectiveness and Resource Allocation, vol. 9, no. 1, p. 11, 2011.
A. Cheung, Lavis, J. N., Hamandi, A., El-Jardali, F., Sachs, J., and Sewankambo, N., Climate for evidence-informed health systems: A print media analysis in 44 low- and middle-income countries that host knowledge-translation platforms., Health research policy and systems / BioMed Central, vol. 9, p. 7, 2011.
G. Chamie, Wandera, B., Marquez, C., Kato-Maeda, M., Kamya, M. R., Havlir, D. V., and Charlebois, E. D., Identifying locations of recent TB transmission in rural Uganda: a multidisciplinary approach., Trop Med Int Health, vol. 20, no. 4, pp. 537-45, 2015.
A. Cattamanchi, Dowdy, D. W., Davis, L. J., Worodria, W., Yoo, S., Joloba, M., Matovu, J., Hopewell, P. C., and Huang, L., Sensitivity of direct versus concentrated sputum smear microscopy in HIV-infected patients suspected of having pulmonary tuberculosis, BMC Infectious Diseases, vol. 9, no. 1, p. 53, 2009.
B. Castelnuovo, Musaazi, J., Musomba, R., Ratanshi, R. Parkes, and Kiragga, A. N., Quantifying retention during pre-antiretroviral treatment in a large urban clinic in Uganda., BMC Infect Dis, vol. 15, p. 252, 2015.
B. Castelnuovo, Manabe, Y. C., Kiragga, A., Kamya, M., Easterbrook, P., and Kambugu, A., Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort., Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol. 49, no. 6, pp. 965-72, 2009.
B. Castelnuovo, Byakwaga, H., Menten, J., Schaefer, P., Kamya, M., and Colebunders, R., Can response of a pruritic papular eruption to antiretroviral therapy be used as a clinical parameter to monitor virological outcome?, AIDS (London, England), vol. 22, no. 2, pp. 269-73, 2008.
B. Castelnuovo, Nanyonjo, A., Kamya, M., and Ocama, P., Is it safe to switch from stavudine to zidovudine after developing symptomatic hyperlactatemia?, African health sciences, vol. 8, no. 2, pp. 133-4, 2008.